U.S. Pharma Payment Statistics

Key CMS Open Payments figures for U.S. pharmaceutical payments to physicians and hospitals ($13.9B, 1,925 companies, PY2024). All figures are computed directly from the CMS Open Payments Public Use Files and are free to cite.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Key findings

The largest single payer was Novartis Pharmaceuticals Corporation, which reported $676.0M (4.9% of all reported payments).
The 10 largest manufacturers accounted for 38.6% of all reported payments, a concentrated top tier typical of Open Payments data.
By total volume, California received the most pharmaceutical payments of any state: $342.4M.
The largest payment category was Royalty or License, totaling $855.1M.
Across the program, 1,925 manufacturers reported payments to 988,644 physicians and teaching hospitals.
Total reported payments reached $13.9B in CMS Open Payments Program Year 2024.

How to read these figures: counts reflect what manufacturers reported under the Physician Payments Sunshine Act; a reported payment documents a financial relationship, not evidence of wrongdoing. State and recipient totals reflect raw payment volume, not per-capita rates. We do not rank entities by "risk" from raw volume.

Read our methodology for how each figure is sourced, computed, and verified, then explore the data by company, by state, or by payment type.

Compiled from official public sources by the publisher.